Search Within

Ana Alarcon Tomas

  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (4)
  2. Bone Marrow Transplant (4)
  3. CTCR Scholars (4)
  4. Center for Hematologic Malignancies (4)
  5. Department of Medicine (4)
  6. GSK Faculty (4)

More Groups

People
  1. Craig Sauter (4)
  2. Gunjan Shah (4)
  3. Jae Park (4)
  4. Maria Palomba (4)
  5. Michael Scordo (4)
  6. Miguel-Angel Perales (4)

More People

Years
  1. 2023 (1)
  2. 2021 (3)
Publications
  1. Blood (2)
  2. Blood Advances (1)
  3. Nature Medicine (1)
Publishers
  1. American Society of Hematology (3)
  2. Nature Publishing Group (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save